Schistosome membrane proteins as vaccines

International Journal for Parasitology

Volumn 37, Issue 3-4, 2007, Pages 257-263

  Loukas, Alex ^a   Tran, Mai ^a   Pearson, Mark S ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Praziquantel; Proteome; Schistosoma; Tegument; Tetraspanin; Transmembrane; Vaccine

Indexed keywords

ANNEXIN; NEUTRALIZING ANTIBODY; OUTER MEMBRANE PROTEIN; PLASMID DNA; PRAZIQUANTEL; RECOMBINANT VACCINE; SCHISTOSOMA MANSONI PROTEIN 07392; SCHISTOSOMA MANSONI PROTEIN 11921; SCHISTOSOMA MANSONI PROTEIN 23; SCHISTOSOMA MANSONI PROTEIN 29; SCHISTOSOMA VACCINE; TETRASPANIN; TETRASPANIN 1; TETRASPANIN 2; TETRASPANIN B; UNCLASSIFIED DRUG;

DRUG DEVELOPMENT; FLATWORM; PROTEIN; PROTEOMICS; SCHISTOSOMIASIS; VACCINATION;

DRUG TARGETING; GENOMICS; HELMINTH; HUMAN; INTEGUMENT; MEMBRANE POTENTIAL; MORTALITY; NONHUMAN; PARASITE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SCHISTOSOMA; SCHISTOSOMIASIS;

ANIMALS; ANTIGENS, HELMINTH; HUMANS; MEMBRANE PROTEINS; MICE; SCHISTOSOMA; SCHISTOSOMIASIS; VACCINES, SYNTHETIC;

MAMMALIA; SCHISTOSOMA; SCHISTOSOMA MANSONI; SCHISTOSOMATIDAE; VERMES;

EID: 33846866453     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2006.12.001     Document Type: Review

References (55)

1. Al-Sherbiny M., Osman A., Barakat R., El Morshedy H., Bergquist R., and Olds R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop. 88 (2003) 117-130
2. Andre M., Le Caer J.P., Greco C., Planchon S., El Nemer W., Boucheix C., Rubinstein E., Chamot-Rooke J., and Le Naour F. Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS. Proteomics 6 (2006) 1437-1449
3. Bergquist N.R., and Colley D.G. Schistosomiasis vaccines: research and development. Parasitol. Today 14 (1998) 99-104
4. Bergquist N.R., Leonardo L.R., and Mitchell G.F. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?. Trends Parasitol. 21 (2005) 112-117
5. Braschi S., Curwen R.S., Ashton P.D., Verjovski-Almeida S., and Wilson A. The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics 6 (2006) 1471-1482
6. Braschi S., and Wilson R.A. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol. Cell Proteomics 5 (2006) 347-356
7. Cardoso F.C., Pacifico R.N., Mortara R.A., and Oliveira S.C. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin. Exp. Immunol. 144 (2006) 382-391
8. Correa-Oliveira R., Pearce E.J., Oliveira G.C., Golgher D.B., Katz N., Bahia L.G., Carvalho O.S., Gazzinelli G., and Sher A. The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans. R. Soc. Trop. Med. Hyg. 83 (1989) 798-804
9. Correa-Oliveira R., Caldas I.R., and Gazzinelli G. Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol. Today 16 (2000) 397-399
10. Correnti J.M., Brindley P.J., and Pearce E.J. Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol. Biochem. Parasitol. 143 (2005) 209-215
11. Da'dara A.A., Skelly P.J., Wang M.M., and Harn D.A. Immunization with plasmid DNA encoding the integral membrane protein. Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 20 (2001) 359-369
12. Da'Dara A.A., Skelly P.J., Walker C.M., and Harn D.A. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection. Parasite Immunol. 25 (2003) 429-437
13. Eberl M., Langermans J.A., Frost P.A., Vervenne R.A., van Dam G.J., Deelder A.M., Thomas A.W., Coulson P.S., and Wilson R.A. Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infect Immun. 69 (2001) 5352-5362
14. El-Sayed N.M., Bartholomeu D., Ivens A., Johnston D.A., and LoVerde P.T. Advances in schistosome genomics. Trends Parasitol. 20 (2004) 154-157
15. Fan J., and Brindley P.J. Characterization of cDNAs encoding a new family of tetraspanins from schistosomes - the Sj25 family. Gene 219 (1998) 1-8
16. Garba A., Toure S., Dembele R., Bosque-Oliva E., and Fenwick A. Implementation of national schistosomiasis control programmes in West Africa. Trends Parasitol. 22 (2006) 322-326
17. Harn D.A., Mitsuyama M., Huguenel E.D., and David J.R. Schistosoma mansoni: detection by monoclonal antibody of a 22,000-dalton surface membrane antigen which may be blocked by host molecules on lung stage parasites. J. Immunol. 135 (1985) 2115-2120
18. Hewitson J.P., Hamblin P.A., and Mountford A.P. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol. 27 (2005) 271-280
19. Hockley D.J., and McLaren D.J. Schistosoma mansoni: changes in the outer membrane of the tegument during development from cercaria to adult worm. Int. J. Parasitol. 3 (1973) 13-25
20. Hoffmann K.F., Wynn T.A., and Dunne D.W. Cytokine-mediated host responses during schistosome infections; walking the fine line between immunological control and immunopathology. Adv. Parasitol. 52 (2002) 265-307
21. Hotez P., and Ferris M. The antipoverty vaccines. Vaccine 24 (2006) 5787-5799
22. Hotez P., Ottesen E., Fenwick A., and Molyneux D. The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination. Adv. Exp. Med. Biol. 582 (2006) 23-33
23. Hotez P.J., Bethony J., Bottazzi M.E., Brooker S., Diemert D., and Loukas A. New technologies for the control of human hookworm infection. Trends Parasitol. 22 (2006) 327-331
24. Hotez P.J., Molyneux D.H., Fenwick A., Ottesen E., Ehrlich Sachs S., and Sachs J.D. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 3 (2006) e102
25. Jankovic D., Wynn T.A., Kullberg M.C., Hieny S., Caspar P., James S., Cheever A.W., and Sher A. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. J. Immunol. 162 (1999) 345-351
26. Jones M.K. Structure and diversity of cestode epithelia. Int. J. Parasitol. 28 (1998) 913-923
27. Jones M.K., Gobert G.N., Zhang L., Sunderland P., and McManus D.P. The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions. Bioessays 26 (2004) 752-765
28. Kabatereine N.B., Fleming F.M., Nyandindi U., Mwanza J.C., and Blair L. The control of schistosomiasis and soil-transmitted helminths in East Africa. Trends Parasitol. 22 (2006) 332-339
29. Kabatereine, N.B., Brooker, S., Koukounari, A., Kazibwe, F., Tukahebwa, E.M., Fleming, F.M., Zhang, Y., Webster, J.P., Stothard, R., Fenwick, A., in press. Impact on infection and morbidity of a national helminth control programme in Ugandan schoolchildren. Bull. World Health Org.
30. Kariuki T.M., Farah I.O., Yole D.S., Mwenda J.M., Van Dam G.J., Deelder A.M., Wilson R.A., and Coulson P.S. Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Infect Immun. 72 (2004) 5526-5529
31. King C.H., Dickman K., and Tisch D.J. Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365 (2005) 1561-1569
32. Knudsen G.M., Medzihradszky K.F., Lim K.C., Hansell E., and McKerrow J.H. Proteomic analysis of Schistosoma mansoni cercarial secretions. Mol. Cell Proteomics 4 (2005) 1862-1875
33. Levy S., and Shoham T. The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 5 (2005) 136-148
34. Liu F., Lu J., Hu W., Wang S.Y., Cui S.J., Chi M., Yan Q., Wang X.R., Song H.D., Xu X.N., Wang J.J., Zhang X.L., Zhang X., Wang Z.Q., Xue C.L., Brindley P.J., McManus D.P., Yang P.Y., Feng Z., Chen Z., and Han Z.G. New perspectives on host-parasite interplay by comparative transcriptomic and proteomic analyses of Schistosoma japonicum. PLoS Pathog. 2 (2006) e29
35. Loukas A., Bethony J.M., Brooker S., and Hotez P.J. Hookworm vaccines - past, present and future. Lancet Infect. Dis. 6 (2006) 733-741
36. Luke T.C., and Hoffman S.L. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J. Exp. Biol. 206 (2003) 3803-3808
37. McLaren D.J., and Hockley D.J. Blood flukes have a double outer membrane. Nature 269 (1977) 147-149
38. Minard P., Dean D.A., Jacobson R.H., Vannier W.E., and Murrell K.D. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am. J. Trop. Med. Hyg. 27 (1978) 76-86
39. Organization, W.H., 2002. Prevention and control of schistosomiasis and soil-transmistted helminthiasis: report of a WHO expert committee. In: WHO, Geneva, pp. 2-5.
40. Pearson M.S., McManus D.P., Smyth D.J., Lewis F.A., and Loukas A. In vitro and in silico analysis of signal peptides from the human blood fluke, Schistosoma mansoni. FEMS Immunol. Med. Microbiol. 45 (2005) 201-211
41. Rabinovich N.R. The renaissance in global health. Trends Parasitol. 22 (2006) 277
42. Racoosin E.L., Davies S.J., and Pearce E.J. Caveolae-like structures in the surface membrane of Schistosoma mansoni. Mol. Biochem. Parasitol. 104 (1999) 285-297
43. Ribeiro de Jesus A., Araujo I., Bacellar O., Magalhaes A., Pearce E., Harn D., Strand M., and Carvalho E.M. Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect. Immun. 68 (2000) 2797-2803
44. Siddiqui A.A., Phillips T., Charest H., Podesta R.B., Quinlin M.L., Pinkston J.R., Lloyd J.D., Pompa J., Villalovos R.M., and Paz M. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation. Vaccine 21 (2003) 2882-2889
45. Skelly P.J., and Shoemaker C.B. Rapid appearance and asymmetric distribution of glucose transporter SGTP4 at the apical surface of intramammalian-stage Schistosoma mansoni. Proc. Natl. Acad. Sci. USA 93 (1996) 3642-3646
46. Skelly P.J., and Shoemaker C.B. The Schistosoma mansoni host-interactive tegument forms from vesicle eruptions of a cyton network. Parasitology 122 (2001) 67-73
47. Smyth D., McManus D.P., Smout M.J., Laha T., Zhang W., and Loukas A. Isolation of cDNAs encoding secreted and transmembrane proteins from Schistosoma mansoni by a signal sequence trap method. Infect. Immun. 71 (2003) 2548-2554
48. Stek M.F., Minard P., Dean D.A., and Hall J.E. Immunization of Baboons with Schistosoma mansoni Cercariae attenuated by gamma irradiation. Science 212 (1981) 1518-1520
49. Tran M.H., Pearson M.S., Bethony J.M., Smyth D.J., Jones M.K., Duke M., Don T.A., McManus D.P., Correa-Oliveira R., and Loukas A. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat. Med. 12 (2006) 835-840
50. van Balkom B.W., van Gestel R.A., Brouwers J.F., Krijgsveld J., Tielens A.G., Heck A.J., and van Hellemond J.J. Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J. Proteome Res. 4 (2005) 958-966
51. Van Hellemond J.J., Retra K., Brouwers J.F., van Balkom B.W., Yazdanbakhsh M., Shoemaker C.B., and Tielens A.G. Functions of the tegument of schistosomes: clues from the proteome and lipidome. Int. J. Parasitol. 36 (2006) 691-699
52. Verjovski-Almeida S., DeMarco R., Martins E.A., Guimaraes P.E., Ojopi E.P., Paquola A.C., Piazza J.P., Nishiyama Jr. M.Y., Kitajima J.P., Adamson R.E., Ashton P.D., Bonaldo M.F., Coulson P.S., Dillon G.P., Farias L.P., Gregorio S.P., Ho P.L., Leite R.A., Malaquias L.C., Marques R.C., Miyasato P.A., Nascimento A.L., Ohlweiler F.P., Reis E.M., Ribeiro M.A., Sa R.G., Stukart G.C., Soares M.B., Gargioni C., Kawano T., Rodrigues V., Madeira A.M., Wilson R.A., Menck C.F., Setubal J.C., Leite L.C., and Dias-Neto E. Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat. Genet. 35 (2003) 148-157
53. Viana I.R., Sher A., Carvalho O.S., Massara C.L., Eloi-Santos S.M., Pearce E.J., Colley D.G., Gazzinelli G., and Correa-Oliveira R. Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 88 (1994) 466-470
54. Walter K., Fulford A.J., McBeath R., Joseph S., Jones F.M., Kariuki H.C., Mwatha J.K., Kimani G., Kabatereine N.B., Vennervald B.J., Ouma J.H., and Dunne D.W. Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens. J. Immunol. 177 (2006) 5490-5498
55. Wilson R.A., and Barnes P.E. The tegument of Schistosoma mansoni: observations on the formation, structure and composition of cytoplasmic inclusions in relation to tegument function. Parasitology 68 (1974) 239-258